Johnny Högberg new CEO of Flemingsberg Science

On 1st November, Johnny Högberg will take over as Chief Executive Officer of the Flemingsberg Science Foundation.

The Foundation’s task is to develop southern Stockholm where clinical care and research are already strongly established with world-leading Karolinska University Hospital, the Karolinska Institute, the Royal Institute of Technology (KTH), Södertörn University and several other academies. Flemingsberg Science will contribute to making the Stockholm region one of the five leading Life Science regions in the world.

Johnny Högberg comes from Skellefteå Science City, where he was CEO, and replaces Björn Varnestig, who is giving up his post as CEO in connection with his 65th birthday.

“I am really looking forward to taking on the role of CEO of Flemingsberg Science. The Stockholm region is a strong area of growth in Europe with high ambitions for Life Science in particular. The fact that the region has the stated goal of attracting the EU’s new Health Emergency Preparedness and Response Authority (HERA) is one of several examples of how these ambitions are expressed in practice,” says Johnny Högberg, incoming CEO of Flemingsberg Science.

The foundation’s Chair, Financial Region Councillor Irene Svenonius (M), is pleased with the recruitment of the new CEO.

“We want to improve conditions for growth and development in Flemingsberg and the surrounding area. This will take place in a broad collaboration between the academies, municipalities and the regional authority, with both healthcare and expanded public transport. To achieve our high goals of attracting new companies, EU authorities, headquarters, investments and research, we need people with Johnny’s experience and knowledge,” says Irene Svenonius.

Fresh start for flooring that reduces fall injuries

A new flooring technology can drastically reduce fall injuries among the elderly. Rubber spikes activate in the event of a sudden impact and can prevent, for example, femoral fractures. The technology is based on KTH research and was initially developed with the support of the Kraftcentrum Flemingsberg program.

ANA Futura further strengthens Campus Flemingsberg

ANA Futura is officially inaugurated at Campus Flemingsberg – a unique research environment focused on bringing down boundaries: boundaries between research and education, as well as between academia and the community.

New multi-million kronor agreement for Sprint Bioscience

Sprint Bioscience and LG Chem have signed a cooperation and licensing agreement for research, development and commercialization of drug candidates. “We’re delighted about the agreement with LG Chem, an ideal partner to further develop this programme,” says Dr Anders Åberg, Sprint Bioscience CEO.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

CF_logo_neg
2021-09-10T10:55:03+02:00
Go to Top